<DOC>
	<DOCNO>NCT02722356</DOCNO>
	<brief_summary>The propose study prospective , randomize , active control , open label study . One hundred sixty subject undergo elective cesarean section randomly assign one two group ( n = 80 per group ) : oxytocin protocol group standard practice group . The oxytocin protocol group receive oxytocin bolus along regulated infusion accord stepwise algorithm follow delivery placenta . The standard practice group receive oxytocin via free flowing ( `` wide-open '' ) infusion concentration 30 IU per 500 mL 0.9 % normal saline follow delivery placenta . Primary outcome include uterine tone ( adequate inadequate ) assess surgeon , amount time require establish adequate uterine tone follow delivery infant , total dose oxytocin require establish adequate uterine tone , total calculate blood loss base pre-operative post-operative hematocrit concentration . Secondary outcome include total estimated blood loss agree upon surgeon anesthesia provider , use additional uterotonic drug , mean arterial pressure , incidence oxytocin side effect ( nausea , chest tightness/pain , ST-segment change ) .</brief_summary>
	<brief_title>Outcomes After Implementation New Oxytocin Protocol</brief_title>
	<detailed_description>The propose study prospective , randomize , active control , open label subject design . One hundred sixty subject randomly assign one two group ( n = 80 per group ) : oxytocin protocol group standard practice group . The following summary procedure use study : 1 . All patient schedule elective cesarean section prescreened investigator assign student register nurse anesthetist ( SRNA ) case . After obtain informed consent HIPAA authorization , full screening eligibility conduct investigator . If determine eligible , subject enrol study assign unique study code . Study code assign sequentially ( 001 , 002 , 003 , etc. ) . Subjects randomly allocate one two group use computer generate random number program . 2 . Prior schedule cesarean section investigator record subject 's age , height , weight , body mass index ( BMI ) , parity , gestational age . Baseline vital sign obtain start anesthesia ( blood pressure , mean arterial pressure , heart rate , respiratory rate , pulse oximetry , temperature ) . A pre-operative complete blood count ( CBC ) drawn order obtain baseline hematocrit concentration . Procedures section part standard clinical care . 3 . All subject 18-gauge IV catheter place leave right upper extremity Lactated Ringer 's solution administer anesthesia provider 's discretion . Standard monitor apply blood pressure set cycle 3-minute interval . Procedures section part standard clinical care . 4 . Neuraxial anesthesia administer anesthesia provider 's discretion base patient assessment . A T4 sensory level establish prior begin cesarean section . Procedures section part standard clinical care . 5 . Heart rate , ECG rhythm ST-segment analysis , end-tidal carbon dioxide ( CO2 ) , temperature , pulse oximetry monitor continuously throughout procedure . Blood pressure mean arterial pressure measure three-minute interval . A Foley catheter insert used measure urine output . Procedures section part standard clinical care . 6 . Throughout procedure vasopressor drug , crystalloids , colloid administer anesthesia provider 's discretion . Procedures section part standard clinical care . 7 . Immediately delivery placenta , oxytocin administer per allocate group ( see ) . The surgeon blind treatment group . 8 . The surgeon ass uterine tone 3 , 6 , 9 minute follow first dose oxytocin deem adequate inadequate . 9 . Subject complaint nausea chest tightness/pain time first dose oxytocin record . 10 . At conclusion cesarean section , amount time require establish adequate uterine tone follow delivery placenta total dose oxytocin require establish adequate uterine tone record . 11 . Estimated blood loss agree upon surgeon anesthesia provider , need additional uterotonic drug , total fluid requirement ( crystalloids , colloid , blood product ) , total urine output , surgical time also record conclusion procedure . 12 . A post-operative CBC drawn 24 hour procedure use calculate blood loss base change pre-operative hematocrit concentration . Procedures section part standard clinical care . 13 . Data record manually data collection sheet procedure transfer electronic data spreadsheet . No identify patient information use data collection sheet electronic data spreadsheet ; subject identify unique study code . 14 . Data collect statistically analyze . Means , standard deviation , covariance calculate group . Patient characteristic age , weight , parity , prior cesarean section , gestational age , baseline hematocrit analyze use multivariate analysis variance ( MANOVA ) order determine group equivalent parameter . An independent t-test use analyze difference group continuous variable : time adequate uterine tone , total oxytocin dose , estimate blood loss , calculate blood loss . A Fisher 's exact test use analyze difference group categorical variable : uterine tone 3 , 6 , 9 minute ( adequate/inadequate ) , use additional uterotonics , incidence nausea , incidence chest pain/tightness , incidence ST-segment change . A repeated measure analysis variance ( ANOVA ) group between-subjects factor time within-subjects use analyze difference group relative mean arterial pressure . If significance detect , post hoc comparison make use Tukey honestly significant difference test . Oxytocin Protocol Group Upon delivery placenta confirmation surgeon , 3 international unit ( IU ) oxytocin administer via slow intravenous ( IV ) push 30 second oxytocin infusion initiate 3 IU per hour ( 50 mL/hr regulate IV pump ) . Investigators wait three minute reassess uterine tone . If uterine tone inadequate , additional 3 IU bolus oxytocin administer via slow IV push 30 second oxytocin infusion increase 6 IU per hour ( 100 mL/hr ) . Investigators wait additional three minute reassess uterine tone . If uterine tone continue inadequate , another 3 IU bolus oxytocin administer via slow IV push 30 second oxytocin infusion increase 9 IU per hour ( 150 mL/hr ) . The investigator wait additional three minute reassess uterine tone . If uterine tone continue inadequate , alternative uterotonic administer surgeon 's discretion ( methylergonovine 0.2 mg intramuscular [ IM ] , carboprost tromethamine 0.25 mg IM intramyometrial , misoprostol 600 mcg buccal 800-1000 mcg rectal ) . In event surgeon determine additional uterotonics require prior third dose oxytocin , subject exclude study additional uterotonics administer necessary . Similarly , event surgeon determines supplementary oxytocin require protocol follow , subject exclude study additional oxytocin administer necessary . Standard Practice Group Upon delivery placenta , free-flowing ( `` wide-open '' ) oxytocin infusion initiate . The oxytocin infusion regulate anesthesia provider 's discretion standard IV tube roll-clamp adjustment make necessary conferring surgeon . If adequate uterine tone achieve reasonable timeframe , surgeon may request additional 20 unit oxytocin add infusion , thereby increase total dose oxytocin 500 mL bag 30 unit 50 unit . Additional uterotonics may request time surgeon 's discretion ( methylergonovine 0.2 mg IM , carboprost tromethamine 0.25 mg IM intramyometrial , misoprostol 600 mcg buccal 800-1000 mcg rectal ) .</detailed_description>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Pregnant woman American Society Anesthesiologists ( ASA ) physical status II ( subject ASA physical status III base solely body mass index [ BMI ] â‰¥ 40 include study ) Over 18 year age Undergoing elective cesarean section neuraxial anesthesia Maternal obstetrician refusal Multiple gestation Ruptured membrane Abnormal placentation Preexisting coagulopathy Macrosomia Chorioamnionitis Diabetes mellitus ( preexist , gestational ) Uterine fibroid Contraindication neuraxial anesthesia Previous allergic reaction synthetic oxytocin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>